Our top pick for
Beginners

Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
Rafael Holdings, Inc is a biotechnology business based in the US. Rafael shares (RFL) are listed on the NYSE and all prices are listed in US Dollars. Rafael employs 54 staff and has a trailing 12-month revenue of around USD$4.8 million.
Our top pick for
Beginners
Our top pick for
Building a portfolio
Our top pick for
Mobile users
Latest market close | USD$23.32 |
---|---|
52-week range | USD$9.4 - USD$26.6325 |
50-day moving average | USD$21.9268 |
200-day moving average | USD$17.4154 |
Wall St. target price | N/A |
PE ratio | N/A |
Dividend yield | N/A (0%) |
Earnings per share (TTM) | USD$-0.354 |
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $23.32 from 2020-12-31
1 week (2021-01-08) | -10.62% |
---|---|
1 month (2020-12-15) | 11.90% |
3 months (2020-10-15) | 31.16% |
6 months (2020-07-15) | 68.62% |
1 year (2020-01-15) | 15.16% |
---|---|
2 years (2019-01-15) | 79.12% |
3 years (2018-01-12) | N/A |
5 years (2016-01-12) | N/A |
Revenue TTM | USD$4.8 million |
---|---|
Gross profit TTM | USD$4.9 million |
Return on assets TTM | -4.28% |
Return on equity TTM | -7.85% |
Profit margin | -215.93% |
Book value | $7.3 |
Market capitalisation | USD$389.5 million |
TTM: trailing 12 months
There are currently 172,940 Rafael shares held short by investors – that's known as Rafael's "short interest". This figure is 3.5% down from 179,178 last month.
There are a few different ways that this level of interest in shorting Rafael shares can be evaluated.
Rafael's "short interest ratio" (SIR) is the quantity of Rafael shares currently shorted divided by the average quantity of Rafael shares traded daily (recently around 28258.169934641). Rafael's SIR currently stands at 6.12. In other words for every 100,000 Rafael shares traded daily on the market, roughly 6120 shares are currently held short.
However Rafael's short interest can also be evaluated against the total number of Rafael shares, or, against the total number of tradable Rafael shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Rafael's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 Rafael shares in existence, roughly 10 shares are currently held short) or 0.0121% of the tradable shares (for every 100,000 tradable Rafael shares, roughly 12 shares are currently held short).
A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Rafael.
Find out more about how you can short Rafael stock.
We're not expecting Rafael to pay a dividend over the next 12 months.
Over the last 12 months, Rafael's shares have ranged in value from as little as $9.4 up to $26.6325. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Rafael's is 2.3877. This would suggest that Rafael's shares are significantly more volatile than the average for this exchange and represent a higher risk.
Rafael Holdings, Inc. owns commercial real estate assets and interests in pre-clinical and clinical stage pharmaceutical companies. The company operates in two segments, Pharmaceuticals and Real Estate. It engages in the leasing of a commercial office building, as well as an associated 800-car public garage; and development and commercialization of therapies that exploit the metabolic differences between normal cells and cancer cells. Rafael Holdings, Inc. is headquartered in Newark, New Jersey.
Everything we know about the Gold Royalty Corp IPO, plus information on how to buy in.
Everything we know about the Bustle Digital Group IPO, plus information on how to buy in.
Everything we know about the Lucid Motors IPO, plus information on how to buy in.
Steps to owning and managing HFFG, with 24-hour and historical pricing before you buy.
Steps to owning and managing HASI, with 24-hour and historical pricing before you buy.
Steps to owning and managing GRIF, with 24-hour and historical pricing before you buy.
Steps to owning and managing FSBW, with 24-hour and historical pricing before you buy.
Steps to owning and managing FNWB, with 24-hour and historical pricing before you buy.
Steps to owning and managing FXNC, with 24-hour and historical pricing before you buy.
Steps to owning and managing FMNB, with 24-hour and historical pricing before you buy.